A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Rochdale MP Simon Danczuk says his battle to expose abuse left him depressed and helped wreck his marriage.
Police are searching for three men after a victim suffered fractured eye sockets in an attack outside a club in Manchester city centre.
Singer Linda Nolan, who was accused of being a benefits cheat, says she was "scared to death" of appearing in court.